Tag - Anavex

Developments

Anavex reports gut microbiota linked to improved ANAVEX2-73 response

Anavex Life Sciences (NASDAQ:AVXL) reported that Alzheimer’s disease (AD) patients with high levels of two gut microbiota families had an improved response to ANAVEX2-73. ANAVEX2-73 is an orally-administered liquid...

July 19, 2019

Feature

Anavex readies trial of AZ combo drug

By Len Zehr Anavex Life Sciences (OTCQB:AVXL) plans to begin a Phase 1b/2a clinical trial in the first quarter of 2014 of a novel combination drug candidate for the treatment of Alzheimer’s disease (AD). “In preclinical...

December 17, 2013

Tag - Anavex

Anavex reports gut microbiota linked to improved ANAVEX2-73 response

Anavex readies trial of AZ combo drug

General

More